ترمب: تعريفات جمركية بنسبة 100% على أدوية العلامات التجارية

U.S. President Donald Trump announced a new round of tariffs that includes a 100% tax on brand-name or patented drugs starting October 1, unless the manufacturing companies build factories in the United States.

The decision focuses on brand-name drugs or those protected by patents or other intellectual property rights, which prevents competition from generic or equivalent drugs until this protection expires.

He clarified in a post on his platform "Truth Social" that this measure will not apply to companies that establish drug manufacturing plants in the United States, and the exemption includes projects that have begun construction or are under construction.

Trump believes that these tariffs will encourage pharmaceutical companies to move their manufacturing operations to the United States.